The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis
Open accessAbstract
Atherothrombotic vascular disease is often triggered by a distinct type of atherosclerotic lesion that displays features of impaired inflammation resolution, notably a necrotic core and thinning of a protective fibrous cap that overlies the core. A key cause of plaque necrosis is defective clearance of apoptotic cells, or efferocytosis, by lesional macrophages, but the mechanisms underlying defective efferocytosis and its possible links to impaired resolution in atherosclerosis are incompletely understood. Here, we provide evidence that proteolytic cleavage of the macrophage efferocytosis receptor c-Mer tyrosine kinase (MerTK) reduces efferocytosis and promotes plaque necrosis and defective resolution. In human carotid plaques, MerTK cleavage correlated with plaque necrosis and the presence of ischemic symptoms. Moreover, in fat-fed LDL receptor-deficient (Ldlr-/-) mice whose myeloid cells expressed a cleavage-resistant variant of MerTK, atherosclerotic lesions exhibited higher macrophage MerTK, lower levels of the cleavage product soluble Mer, improved efferocytosis, smaller necrotic cores, thicker fibrous caps, and increased ratio of proresolving versus proinflammatory lipid mediators. These findings provide a plausible molecular-cellular mechanism that contributes to defective efferocytosis, plaque necrosis, and impaired resolution during the progression of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Levels of the cleaved product, soluble MER, increase in advancing atherosclerosis in both mice and humans and can compete with MERTK for binding of GAS6 and protein S and thereby compromise efferocytosis in the lesion162.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [162]
In the citing paper
“Athero-prone mice genetically engineered to express cleavage-resistant MERTK show a decreased propensity to develop necrotic cores compared with control mice162.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Mechanisms of plaque formation and rupture
Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,219
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Self-citationTAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
Gagliani, N., Vesely, M. C. A., Iseppon, A., Brockmann, L., Xu, H. Y., Palm, N. W., de Zoete, M. R., Licona-Limón, P., Paiva, R., Ching, T. H., et al. (2015) · Nature · doi:10.1038/nature14452 · Cited by 830
Flagged first, then by citations
Cited by
Sorted by citations
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationInflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Self-citationEfferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066
Self-citationTargeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,085
Cochain, C., Vafadarnejad, E., Arampatzi, P., Pelisek, J., Winkels, H., Ley, K., Wolf, D., Saliba, A.-E., & Zernecke, A. (2018) · Circulation Research · doi:10.1161/circresaha.117.312509 · Cited by 894
Monocyte-macrophages and T cells in atherosclerosis
Tabas, I., & Lichtman, A. H. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.008 · Cited by 646
Self-citationYurdagul, A., Subramanian, M., Wang, X., Crown, S. B., Ilkayeva, O. R., Darville, L., Kolluru, G. K., Rymond, C. C., Gerlach, B. D., Zheng, Z., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.001 · Cited by 525
Self-citationDrugging the efferocytosis process: concepts and opportunities
Mehrotra, P., & Ravichandran, K. S. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00470-y · Cited by 459
Macrophages and lipid metabolism
Remmerie, A., & Scott, C. L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.020 · Cited by 451
Macrophages: The Good, the Bad, and the Gluttony
Ross, E. A., Devitt, A., & Johnson, J. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708186 · Cited by 450
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A., Zurke, Y.-X., & Monaco, C. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 455
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
Morioka, S., Maueröder, C., & Ravichandran, K. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.018 · Cited by 391
Koyama, S., Ito, K., Terao, C., Akiyama, M., Horikoshi, M., Momozawa, Y., Matsunaga, H., Ieki, H., Ozaki, K., Onouchi, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0705-3 · Cited by 353
Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages
Wang, Y., Subramanian, M., Yurdagul, A., Barbosa-Lorenzi, V. C., Cai, B., de Juan-Sanz, J., Ryan, T. A., Nomura, M., Maxfield, F. R., & Tabas, I. (2017) · Cell · doi:10.1016/j.cell.2017.08.041 · Cited by 364
Self-citationMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 418
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.015 · Cited by 360
Self-citationWu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02041-7 · Cited by 354
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300
Self-citationMacrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., Zheng, Z., Kasikara, C., Davra, V., Meroni, M., Chung, R. T., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.013 · Cited by 266
Self-citationThe role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Self-citationMacrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice
Wang, W., Liu, W., Fidler, T., Wang, Y., Tang, Y., Woods, B., Welch, C., Cai, B., Silvestre-Roig, C., Ai, D., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313283 · Cited by 262
Self-citationDeBerge, M., Yeap, X. Y., Dehn, S., Zhang, S., Grigoryeva, L. S., Misener, S., Procissi, D., Zhou, X., Lee, D. C., Müller, W. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311327 · Cited by 250
Self-citationMacrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis
Moore, K. J., Koplev, S., Fisher, E. A. A., Tabas, I. A., Björkegren, J., Doran, A. C., & Kovacic, J. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2147 · Cited by 229
Self-citationErythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage
Chang, C.-F., Goods, B. A., Askenase, M. H., Hammond, M. D., Renfroe, S. C., Steinschneider, A. F., Landreneau, M. J., Ai, Y., Beatty, H. E., da Costa, L. H. A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95612 · Cited by 217
Cai, B., Kasikara, C., Doran, A. C., Ramakrishnan, R., Birge, R. B., & Tabas, I. (2018) · Science Signaling · doi:10.1126/scisignal.aar3721 · Cited by 175
Self-citationBoosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 179
Self-citationInflammation Resolution: Implications for Atherosclerosis
Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 181
Self-citationVascular Macrophages in Atherosclerosis
Xu, H., Jiang, J., Chen, W., Li, W., & Chen, Z. (2019) · Journal of Immunology Research · doi:10.1155/2019/4354786 · Cited by 176
Efferocytosis in atherosclerosis
Adkar, S. S., & Leeper, N. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01037-7 · Cited by 182
Macrophages in vascular inflammation and atherosclerosis
Cochain, C., & Zernecke, A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1941-y · Cited by 168
Macrophage Plasticity and Atherosclerosis Therapy
Lin, P. C., Ji, H., Li, Y., & Guo, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.679797 · Cited by 172
Fredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 176
Self-citationFoam Cells: One Size Doesn’t Fit All
Guerrini, V., & Gennaro, M. L. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.002 · Cited by 164
The role of phosphatidylserine recognition receptors in multiple biological functions
Naeini, M. B., Bianconi, V., Pirro, M., & Sahebkar, A. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00214-z · Cited by 163
How neutrophils meet their end
Lawrence, S. M., Corriden, R., & Nizet, V. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.008 · Cited by 144
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134
Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability
Yurdagul, A. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316233 · Cited by 138
TREM2 protects from atherosclerosis by limiting necrotic core formation
Piollet, M., Porsch, F., Rizzo, G., Kapser, F., Schulz, D., Kiss, M. G., Schlepckow, K., Morenas‐Rodríguez, E., Sen, M. O., Gropper, J., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00429-9 · Cited by 130
Resolvin D1 promotes efferocytosis in aging by limiting senescent cell‐induced MerTK cleavage
Rymut, N., Heinz, J., Sadhu, S., Hosseini, Z., Riley, C. O., Marinello, M., Maloney, J., MacNamara, K. C., Spite, M. R., & Fredman, G. (2019) · The FASEB Journal · doi:10.1096/fj.201902126r · Cited by 117
Self-citationDoran, A. C., Özcan, L., Cai, B., Zheng, Z., Fredman, G., Rymond, C. C., Dorweiler, B., Sluimer, J. C., Hsieh, J., Kuriakose, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94735 · Cited by 113
Self-citationChakraborty, S., Singh, A., Wang, L. X., Wang, X., Sanborn, M. A., Ye, Z., Maienschein‐Cline, M., Mukhopadhyay, A., Ganesh, B. B., Malik, A. B., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221388 · Cited by 112
Crosstalk between macrophages and cardiac cells after myocardial infarction
Jian, Y., Zhou, X. J., Shan, W., Chen, C., Ge, W., Cui, J., Yi, W., & Sun, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01105-4 · Cited by 114
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Huelse, J. M., Fridlyand, D. M., Earp, S. H., DeRyckere, D., & Graham, D. K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107577 · Cited by 101
Specialized pro-resolving mediators in cardiovascular diseases
Fredman, G., & Spite, M. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.003 · Cited by 103
Self-citationMacrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction
DeBerge, M., Glinton, K. E., Subramanian, M., Wilsbacher, L. D., Rothlin, C. V., Tabas, I. A., & Thorp, E. B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139576 · Cited by 99
Self-citation2016 Russell Ross Memorial Lecture in Vascular Biology
Tabas, I. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308036 · Cited by 92
Self-citationDEL-1-Regulated Immune Plasticity and Inflammatory Disorders
Hajishengallis, G., & Chavakis, T. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.02.010 · Cited by 90
Resolving inflammation by TAM receptor activation
Vago, J. P., Amaral, F. A., & van de Loo, F. A. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107893 · Cited by 92
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Shafit‐Zagardo, B., Gruber, R. C., & DuBois, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.002 · Cited by 89
Yao, Z., Qi, W., Zhang, H., Zhang, Z., Liu, L., Shao, Y., Zeng, H., Yin, J., Pan, H., Guo, X., et al. (2023) · eLife · doi:10.7554/elife.83069 · Cited by 88
Rinne, P., Guillamat‐Prats, R., Rami, M., Bîndilă, L., Ring, L., Lyytikäinen, L., Raitoharju, E., Oksala, N., Lehtimäki, T. J., Weber, C., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311185 · Cited by 88
The many ways tissue phagocytes respond to dying cells
Blander, J. M. (2017) · Immunological Reviews · doi:10.1111/imr.12537 · Cited by 84
Wang, Y., Liu, X.-Y., Wang, Y., Zhao, W.-X., Li, F.-D., Guo, P.-R., Fan, Q., & Wu, X.-F. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102763 · Cited by 85
Wu, Y., Zhang, Y., Dai, L., Wang, Q., Xue, L., Su, Z., & Zhang, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.043 · Cited by 78
Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity
Tu, H., Ren, H., Jiang, J., Shao, C., Shi, Y., & Li, P. (2023) · Advanced Science · doi:10.1002/advs.202306457 · Cited by 80
Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability—Brief Report
Patterson, M. T., Xu, Y., Hillman, H., Osinski, V., Schrank, P. R., Kennedy, A. E., Barrow, F., Zhu, A., Tollison, S., Shekhar, S., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.320797 · Cited by 76
Yang, S., Xia, Y., Luo, X., Chen, S., Li, B., Ye, Z.-M., Chen, S., Mao, L., Jin, H., Li, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.011 · Cited by 77
Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models
Waterborg, C. E. J., Beermann, S., Broeren, M. G. A., Bennink, M. B., Koenders, M. I., van Lent, P. L. E. M., van den Berg, W. B., van der Kraan, P. M., & van de Loo, F. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00742 · Cited by 75
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 74
Rayner, K. J. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309229 · Cited by 68
Regulation of Apoptotic Cell Clearance During Resolution of Inflammation
Arienti, S., Barth, N. D., Dorward, D. A., Rossi, A. G., & Dransfield, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00891 · Cited by 65
PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging
Liu, S., Wu, J., Stolarz, A. J., Zhang, H., Boerma, M., Byrum, S. D., Rusch, N. J., & Ding, Z. (2023) · Theranostics · doi:10.7150/thno.83914 · Cited by 64
SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin
Gao, J., Huang, C., Kong, L., Zhou, W., Sun, M., Wei, T., & Shen, W. (2023) · Circulation Research · doi:10.1161/circresaha.123.323160 · Cited by 60
TAM receptors in cardiovascular disease
McShane, L., Tabas, I. A., Lemke, G., Kurowska‐Stolarska, M., & Maffia, P. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz100 · Cited by 61
Self-citationTAM receptors in phagocytosis: Beyond the mere internalization of particles
Burstyn‐Cohen, T., & Fresia, R. (2023) · Immunological Reviews · doi:10.1111/imr.13267 · Cited by 61
Rethinking Phagocytes: Clues from the Retina and Testes
Penberthy, K. K., Lysiak, J. J., & Ravichandran, K. S. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.01.004 · Cited by 57
Role of macrophages in pulmonary arterial hypertension
Zhang, M., Wang, C., Pang, X., Shi, J.-Z., Li, H., Xie, X., Wang, Z., Zhang, H., Zhou, Y., Chen, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152881 · Cited by 61
Monocytes as immune targets in arterial hypertension
Wenzel, P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14389 · Cited by 56
Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle
Marques, A. R. A., Ramos, C., Machado-Oliveira, G., & Vieira, O. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658995 · Cited by 53
Helmke, A., Casper, J., Nordlohne, J., David, S., Haller, H. G., Zeisberg, E. M., & von Vietinghoff, S. (2018) · The FASEB Journal · doi:10.1096/fj.201801238r · Cited by 53
Fan, L., Jin, L., Tang, T., Zheng, Y., Chen, Z., Lin, H., Ding, C., Wang, T., Chen, H., Guo, Y., et al. (2023) · Theranostics · doi:10.7150/thno.90370 · Cited by 51
Yurdagul, A., Kong, N., Gerlach, B. D., Wang, X., Ampomah, P. B., Kuriakose, G., Tao, W., Shi, J., & Tabas, I. A. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315622 · Cited by 53
Self-citationQiu, S., Liu, J., Chen, J., Li, Y., Bu, T., Li, Z., Zhang, L., Sun, W., Zhou, T., Hu, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02463-y · Cited by 54
Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages
Wanke, F., Gutbier, S., Rümmelin, A., Steinberg, M., Hughes, L. D., Koenen, M., Komuczki, J., Regan-Komito, D., Wagage, S., Hesselmann, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03770-0 · Cited by 49
Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
Yin, C., Vrieze, A. M., Rosoga, M., Akingbasote, J. A., Pawlak, E. N., Jacob, R. A., Hu, J. K., Sharma, N., Dikeakos, J. D., Barra, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594136 · Cited by 48
Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Gadiyar, V., Lahey, K. C., Calianese, D. C., Devoe, C., Mehta, D., Bono, K. R., Desind, S. Z., Davra, V., & Birge, R. B. (2020) · Cells · doi:10.3390/cells9102207 · Cited by 44
Innate and Innate-Like Immune System in Hypertension and Vascular Injury
Higaki, A., Caillon, A., Paradis, P., & Schiffrin, E. L. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0907-1 · Cited by 43
Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis
Yurdagul, A. (2021) · Immunometabolism · doi:10.20900/immunometab20210017 · Cited by 41
Yang, B., Hang, S., Xu, S., Gao, Y., Yu, W., Zang, G., Zhang, L., & Wang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32073 · Cited by 46
X-Box Binding Protein-1 Dependent Plasma Cell Responses Limit the Development of Atherosclerosis
Sage, A. P., Nus, M., Chakraborty, J. B., Tsiantoulas, D., Newland, S. A., Finigan, A. J., Masters, L. M., Binder, C. J., & Mallat, Z. (2017) · Circulation Research · doi:10.1161/circresaha.117.310884 · Cited by 41
Protocatechuic Acid Inhibits Vulnerable Atherosclerotic Lesion Progression in Older Apoe-/- Mice
Zheng, J., Li, Q., He, L., Weng, H., Su, D., Liu, X., Ling, W., & Wang, D. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa017 · Cited by 43
Dhawan, U. K., Singhal, A., & Subramanian, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105699 · Cited by 41
Gonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 42
Self-citationLiu, W., Hardaway, B. D., Kim, E., Pauli, J., Wettich, J. L., Yalçınkaya, M., Hsu, C.-C., Xiao, T., Reilly, M. P., Tabas, I. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci182939 · Cited by 37
Self-citationMueller, P. A., Kojima, Y., Huynh, K. T., Maldonado, R. A., Ye, J., Tavori, H., Pamir, N., Leeper, N. J., & Fazio, S. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316854 · Cited by 40
Efferocytosis in multisystem diseases (Review)
Zhang, Y., Wang, Y., Ding, J., & Liu, P. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12529 · Cited by 38
Zhang, J., Ding, W. B., Zhao, M., Liu, J., Xu, Y., Wan, J., & Wang, M. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15939 · Cited by 38
Li, Q., Liu, X., Du, Y., Zhang, X., Xiang, P., Chen, G., Ling, W., & Wang, D. (2023) · Science Signaling · doi:10.1126/scisignal.abn1372 · Cited by 36
Exosomes in atherosclerosis: Convergence on macrophages
Yang, K., Xiao, Q., Niu, M., Pan, X., & Zhu, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71862 · Cited by 36
Zhang, L., DeBerge, M., Wang, J., Dangi, A., Zhang, X., Schroth, S. L., Zhang, Z., Thorp, E. B., & Luo, X. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15087 · Cited by 34
Self-citationMutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
Yeh, C., Chen, Y.-H., Liu, S.-F., Kao, H., Wu, M., Yang, K., & Wu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228729 · Cited by 37
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target
Pandit, R., & Yurdagul, A. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01294-y · Cited by 35
Zhang, Y., Ding, J., Wang, Y., Feng, X., Du, M., & Liu, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731769 · Cited by 33
Targeted theranostic photoactivation on atherosclerosis
Song, J. W., Ahn, J. W., Lee, M. W., Kim, H. J., Kang, D. O., Kim, R. H., Kang, U. G., Kim, Y. H., Han, J., Park, Y. H., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01084-z · Cited by 32
Gomes, M. T., Palasiewicz, K., Gadiyar, V., Lahey, K. C., Calianese, D. C., Birge, R. B., & Ucker, D. S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102034 · Cited by 36
Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease
Zheng, D. J., Taka, M. A., & Heit, B. (2021) · Pathogens · doi:10.3390/pathogens10020134 · Cited by 32
Directional Endothelial Communication by Polarized Extracellular Vesicle Release
Raju, S., Botts, S. R., Blaser, M. C., Abdul-Samad, M., Prajapati, K., Khosraviani, N., Ho, T. W. W., Breda, L. C. D., Ching, C., Galant, N. J., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.322993 · Cited by 30
Dhawan, U. K., Vartak, T., Englert, H., Russo, S., Vasconcellos, L. R. C., Singhal, A., Chakraborty, R., Bhagat, K. K., McDonnell, C. O., Connolly, M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326353 · Cited by 35
Pro-Resolving Ligands Orchestrate Phagocytosis
Decker, C., Sadhu, S., & Fredman, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660865 · Cited by 34
Self-citationEfferocytosis in liver disease
Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100960 · Cited by 30
Self-citation
Metadata
- Authors
- Cai, B., Thorp, E. B., Doran, A. C., Sansbury, B. E., Daemen, M. J. A. P., Dorweiler, B., Spite, M., Fredman, G., & Tabas, I.
- Affiliations
- Columbia University (US)
- Northwestern University (US)
- Brigham and Women's Hospital (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Johannes Gutenberg University Mainz (DE)
- Albany Medical College (US)
- Corresponding author
- Tabas, Ira
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-09
- Volume
- 127
- Issue
- 2
- Pages
- 564-568
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5272169
- OpenAlex
- W2569227792
- Cited by
- 262
- References
- 39
- Citations by year
- 2026: 37 · 2025: 34 · 2024: 38 · 2023: 27 · 2022: 23 · 2021: 28 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 16
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Health Research Alliance (cc-by)
- Funders
- American Heart Association (T32 HL007854)
- National Institutes of Health (UL1TR001422, HL119587, HL007854)
- National Heart, Lung, and Blood Institute (R01HL122309, R01HL132412, R01HL140554, R01HL127464, R00HL119587, K99HL119587, P01HL087123, R01HL075662, R01HL106173, T32HL007854)
- National Institute of General Medical Sciences (P01GM095467)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- MERTK, efferocytosis, plaque necrosis, atherosclerosis, inflammation resolution, macrophages, necrotic core, fibrous cap, carotid plaque, specialized pro-resolving mediators, Ldlr-deficient mice, atherothrombosis
- MeSH terms
- c-Mer Tyrosine Kinase, Animals, Carotid Artery Diseases, Female, Humans, Male, Necrosis, Proto-Oncogene Proteins, Receptors, LDL, Mice, Knockout, Receptor Protein-Tyrosine Kinases, Mice, Plaque, Atherosclerotic, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
